Liver Disease Diagnostics Market Set to Reach $52.04 Billion by 2029 with 7% Yearly Growth

What Is the Estimated Market Size and Growth Rate for the Liver Disease Diagnostics Market?
The market size for diagnosing liver diseases has seen notable growth in recent years. The sector, which was valued at $36.26 billion in 2024, is predicted to rise to $39.05 billion in 2025, showing a compound annual growth rate (CAGR) of 7.7%. The increase in the historical period can be linked to the rise in the incidence of both short-term and long-term liver conditions, increasing cases of liver diseases, higher alcohol intake, growing consciousness about liver health, and the development of healthcare infrastructure.

In the coming years, the market size for liver disease diagnostics is predicted to experience robust growth, expanding to $52.04 billion in 2029 with a 7.4% compound annual growth rate (CAGR). The expected growth within this forecast period could be due to factors such as a surging older population, increased research & development expenditures, a growing number of biopsy procedures and diseases, and the larger adoption of telemedicine. Major forecast period trends consist of the emergence of personalized medicine, technological advancements in diagnostic kits and rapid tests, as well as technological progress in the healthcare sector and diagnostic methods.

What Are the Forces Behind the Rapid Growth of the Liver Disease Diagnostics Market?
The rise in alcohol intake is anticipated to spur the expansion of the liver disease diagnostics market in the future. Factors like evolving societal standards, increased affordability, broad accessibility, and escalating stress or mental health issues contribute to the surge in alcohol consumption. Liver disease diagnostics play a pivotal role in observing the effects of alcohol intake on liver health, facilitating the early detection of symptoms of liver damage such as fatty liver, hepatitis, or cirrhosis. For example, the National Health Service, a government agency based in England, reported in December 2022 that the proportion of people who drank alcohol in the previous 12 months increased with age, from 62% among those aged 16 to 24, to 85% among those aged 55 to 74. Consequently, the growing alcohol consumption is fueling the growth of the liver disease diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Who Are the Dominant Companies Influencing Liver Disease Diagnostics Market Trends?
Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

Which Key Developments Are Influencing the Liver Disease Diagnostics Market?
Leading firms in the liver disease diagnostics market are aiming to craft innovative solutions, like non-invasive tools for liver evaluation, to create more precise and effective diagnostic methods. Non-invasive instruments for liver assessment involve diagnostic methodologies that analyze liver health using approaches such as elastography or blood tests, thus potentially eliminating invasive procedures such as biopsies. For example, in September 2024, City Imaging & Clinical, a diagnostics center based in India, introduced FibroScan, a non-invasive diagnostic instrument for liver evaluation. This tool is designed for early discovery of liver conditions like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This state-of-the-art technology assists in swift and precise measurements of liver rigidity and fat content without invasive procedures like biopsies. The operation is quick, often lasting 5 to 15 minutes, and requires a probe to be placed on the skin above the liver. The probe delivers sound waves that gauge liver tissue rigidity, enabling the evaluation of fibrosis or scarring.

What Are the Different Segmentations in the Liver Disease Diagnostics Market?
The liver disease diagnostics market covered in this report is segmented -

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques
2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases
3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:
1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests
2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)
3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy
4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy
5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Region Is at the Forefront of the Liver Disease Diagnostics Market?
North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Liver Disease Diagnostics Global Market Report?

- Market Size Analysis: Analyze the liver disease diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the liver disease diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall liver disease diagnostics market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the liver disease diagnostics market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.